Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-jr42d Total loading time: 0 Render date: 2024-04-24T00:51:21.300Z Has data issue: false hasContentIssue false

12 - Confirmatory testing and donor re-admission

from Section 2 - Selection and testing

Published online by Cambridge University Press:  12 January 2010

Alan D. Kitchen
Affiliation:
Head, National Transfusion Microbiology Reference Laboratory, NHS Blood and Transplant Colindale, London, UK
Brian C. Dow
Affiliation:
Consultant, Clinical Microbiologist; Head, Scottish National Blood Transfusion Service, National Microbiology Reference Unit, West of Scotland, Transfusion Centre, Glasgow, UK
John A. J. Barbara
Affiliation:
University of the West of England, Bristol
Fiona A. M. Regan
Affiliation:
HNSBT and Hammersmith Hospitals NHS Trust, London
Marcela Contreras
Affiliation:
University of the West of England, Bristol
Get access

Summary

Introduction

The major focus in ensuring the microbiological safety of the blood supply relies heavily on the primary screening of donated blood. Although routine donor screening assays are highly sensitive, this sensitivity is often achieved at the expense of specificity (0.05–0.5%) (Dow, 2000).

Blood donations found to be initially reactive at donor testing sites should be repeat tested in duplicate. Should any of the repeat tests result in reactivity, the donation is classified as ‘repeatedly reactive’, the donor is flagged on the donor database and samples are submitted to the designated national reference laboratory or other designated facility. Regardless of confirmatory test results, the donation and all its associated components will be excluded from transfusion.

Throughout the world, blood services have differing policies with regard to confirmation of microbiology reactive donations. Most developed countries' services are capable of performing adequate confirmation of reactive donations. However, some services use an alternative strategy of reporting reactivity directly to the donors, often resulting in considerable donor anxiety and potential personal expense to reach a confirmatory conclusion. Obviously, in areas of high endemicity, there is a higher predictive value associated with a repeat reactive result and in this situation, simpler confirmatory algorithms can be utilized. Generally though, in developed countries, donors have relatively low prevalences of infection and therefore more complex confirmatory algorithms, like those described in this chapter, are often necessary before notification to the apparently healthy volunteer donor.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Allain, J. P., Kitchen, A., Aloysius, S., et al. (1996) Safety and efficacy of hepatitis C virus antibody screening of blood donors with two sequential screening assays. Transfusion, 36, 401–5.CrossRefGoogle ScholarPubMed
Courouce, A. M., Marrec, N. and Boucherdeau, F. (2000) Efficacy of HCV core antigen detection during the preseroconversion period. Transfusion, 40, 1198–1202.CrossRefGoogle ScholarPubMed
Dow, B. C. (1999) Microbiology confirmatory tests for blood donors. Blood Rev, 13, 91–104.CrossRefGoogle ScholarPubMed
Dow, B. C. (2000) ‘Noise’ in microbiological screening assays. Transfus Med, 10, 97–106.CrossRefGoogle ScholarPubMed
Dow, B. C., Buchanan, I., Munro, H., et al. (1996) Relevance of RIBA-3 supplementary test to HCV PCR positivity and genotypes for HCV confirmation of blood donors. J Med Virol, 49, 132–6.3.0.CO;2-G>CrossRefGoogle ScholarPubMed
Dow, B. C., Munro, H., Buchanan, I., et al. (2004) Acute hepatitis C virus seroconversion in a Scottish blood donor: HCV antigen is not comparable with HCV nucleic acid amplification technology screening. Vox Sang, 86, 15–20.CrossRefGoogle Scholar
Dow, B. C., Munro, H., Ferguson, K., et al. (2001) HTLV antibody screening using mini-pools. Transfus Med, 11, 419–22.CrossRefGoogle ScholarPubMed
Dow, B. C., Yates, P., Galea, G., et al. (2002) Hepatitis B vaccinees may be mistaken for confirmed hepatitis B surface antigen-positive blood donors. Vox Sang, 82, 15–17.CrossRefGoogle ScholarPubMed
Grob, P., Jilg, W., Bornhak, H., et al. (2000) Serological pattern ‘anti-HBc alone’: report on a workshop. J Med Virol, 62, 450–5.3.0.CO;2-Y>CrossRefGoogle Scholar
Kitchen, A. D. and Tucker, N. V. (1995) The specificity of anti-HCV supplementary assays. Vox Sang, 69, 100–103.CrossRefGoogle ScholarPubMed
Lee, S. R., Peterson, J., Niven, P., et al. (2001) Efficacy of a hepatitis C virus core antigen enzyme-linked immunosorbent assay for the identification of ‘window-phase’ blood donations. Vox Sang, 80, 19–23.CrossRefGoogle ScholarPubMed
Newham, J. A. and Kitchen, A. D. (2003) Lot release of microbiology blood screening kits in the English National Blood Service. Transfus Med, 13 (1), 55.Google Scholar
Salker, R., Howell, D. R., Moore, M. C., et al. (2001) Early acute hepatitis B infection and hepatitis B vaccination in blood donors. Transfus Med, 11, 463.CrossRefGoogle ScholarPubMed
UK BTS/NIBSC Joint Professional Advisory Committee (2002) Guidelines for the Blood Transfusion Service. 6th edn. Norwich, The Stationery Office.

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Confirmatory testing and donor re-admission
    • By Alan D. Kitchen, Head, National Transfusion Microbiology Reference Laboratory, NHS Blood and Transplant Colindale, London, UK, Brian C. Dow, Consultant, Clinical Microbiologist; Head, Scottish National Blood Transfusion Service, National Microbiology Reference Unit, West of Scotland, Transfusion Centre, Glasgow, UK
  • Edited by John A. J. Barbara, University of the West of England, Bristol, Fiona A. M. Regan, Marcela Contreras, University of the West of England, Bristol
  • Book: Transfusion Microbiology
  • Online publication: 12 January 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545245.016
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Confirmatory testing and donor re-admission
    • By Alan D. Kitchen, Head, National Transfusion Microbiology Reference Laboratory, NHS Blood and Transplant Colindale, London, UK, Brian C. Dow, Consultant, Clinical Microbiologist; Head, Scottish National Blood Transfusion Service, National Microbiology Reference Unit, West of Scotland, Transfusion Centre, Glasgow, UK
  • Edited by John A. J. Barbara, University of the West of England, Bristol, Fiona A. M. Regan, Marcela Contreras, University of the West of England, Bristol
  • Book: Transfusion Microbiology
  • Online publication: 12 January 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545245.016
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Confirmatory testing and donor re-admission
    • By Alan D. Kitchen, Head, National Transfusion Microbiology Reference Laboratory, NHS Blood and Transplant Colindale, London, UK, Brian C. Dow, Consultant, Clinical Microbiologist; Head, Scottish National Blood Transfusion Service, National Microbiology Reference Unit, West of Scotland, Transfusion Centre, Glasgow, UK
  • Edited by John A. J. Barbara, University of the West of England, Bristol, Fiona A. M. Regan, Marcela Contreras, University of the West of England, Bristol
  • Book: Transfusion Microbiology
  • Online publication: 12 January 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545245.016
Available formats
×